Goldline Pharmaceutical Ltd
Fri 25/09/2026,16:1:0 | BSE : GLPL
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 33.75
Previous Close
₹ 32.62
Volume
9000
Mkt Cap ( ₹ Cr)
₹ 31.19
High
₹ 33.75
Low
₹ 32.49
52 Week High
₹ 60.00
52 Week Low
₹ 31.62
Book Value Per Share
₹ 13.80
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Goldline Pharmaceutical Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Goldline Pharmaceutical Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Goldline Pharma. - Intimation Of Record Date For Remote E-Voting
-
Goldline Pharma. - Intimation Of Book Closure Shall Remain Closed From Sunday 23Rd August, 2026 To Saturday 29Th August, 2026
-
Goldline Pharma. - Reg. 34 (1) Annual Report.
-
Goldline Pharma. - Intimation Of Notice Of 22Nd Annual General Meeting Of Goldline Pharmaceutical Limited Will Be Held On Sat
-
Goldline Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Goldline Pharma. - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Goldline Pharmaceutical Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 23.4113 | 21.3838 | 18.9935 | 16.7196 | 17.2066 |
| Liabilities | 23.4113 | 21.3838 | 18.9935 | 16.7196 | 17.2066 |
| Equity | 6.9 | 6.9 | 2.3 | 2 | 2 |
| Gross Profit | 6.9401 | 5.8301 | 4.3011 | 2.1943 | 1.6851 |
| Net Profit | 4.1171 | 2.8322 | 1.804 | 0.2566 | 0.3316 |
| Cash From Operating Activities | 2.8146 | 2.3214 | 2.9224 | 2.3912 | 0 |
| NPM(%) | 13.19 | 10.09 | 7.65 | 1.29 | 1.38 |
| Revenue | 31.1976 | 28.0557 | 23.566 | 19.8484 | 24.0105 |
| Expenses | 24.2575 | 22.2256 | 19.2649 | 17.6541 | 22.3254 |
| ROE(%) | 31.07 | 21.37 | 13.61 | 1.93 | 2.5 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Goldline Pharmaceutical Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 878.15 | 0.90 | 22.10 | 18.54 | -26.19 | 0.57 |
| Lotus Eye Hospital and Institute Ltd | 115.60 | 2.03 | 1643.86 | 67.57 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 12.85 | -3.02 | 0.00 | 140.29 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 737.05 | 1.25 | 0.00 | 72.39 | -363.14 | 0.00 |
Company Info
Our Company was originally incorporated on August 2, 2004, as a private limited company in the name of `Goldline Pharmaceutical Private Limited' under the provisions of the Companies Act, 1956 with the Registrar of Companies, Maharashtra at Mumbai. Subsequently pursuant to a special resolution passed by our Shareholders in the Extra-Ordinary General Meeting held on July 18, 2013, our Company was converted from a private limited company into a public limited company and consequently, the name of our Company was changed to `Goldline Pharmaceutical Limited' and a fresh certificate of incorporation dated September 23, 2013 was issued by the Registrar of Companies, Maharashtra at Mumbai. The Corporate Identity Number of our Company is U51397MH2004PLC147806. Major Events and Milestones:2004- Incorporation of the company as a private company under the name `Goldline Pharmaceutical Private Limited.'2013- Conversion of our company from a private limited company to a public company and the new name of company as `Goldline Pharmaceutical Limited.'
Our Company was originally incorporated on August 2, 2004, as a private limited company in the name of `Goldline Pharmaceutical Private Limited' under the provisions of the Companies Act, 1956 with the Registrar of Companies, Maharashtra at Mumbai. Subsequently pursuant to a special resolution passed by our Shareholders in the Extra-Ordinary General Meeting held on July 18, 2013, our Company was converted from a private limited company into a public limited company and consequently, the name of our Company was changed to `Goldline Pharmaceutical Limited' and a fresh certificate of incorporation dated September 23, 2013 was issued by the Registrar of Companies, Maharashtra at Mumbai. The Corporate Identity Number of our Company is U51397MH2004PLC147806. Major Events and Milestones:2004- Incorporation of the company as a private company under the name `Goldline Pharmaceutical Private Limited.'2013- Conversion of our company from a private limited company to a public company and the new name of company as `Goldline Pharmaceutical Limited.'
Read More
Parent Organisation
Goldline Pharmaceutical Ltd.
Founded
02/08/2004
Managing Director
Mr.Amol Laxmikant Mujumdar
NSE Symbol
FAQ
The current price of Goldline Pharmaceutical Ltd is
The 52-week high for Goldline Pharmaceutical Ltd is
The market capitalization of Goldline Pharmaceutical Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Goldline Pharmaceutical Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Goldline Pharmaceutical Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Goldline Pharmaceutical Ltd shares.
The CEO of Goldline Pharmaceutical Ltd is Mr.Amol Laxmikant Mujumdar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
